Towerview LLC
- SEC CIK
- 0001166573
- Latest filing
- Aug 4, 2026
CRVS holding history
Corvus Pharmaceuticals, Inc. in every 13F filed by Towerview LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CRVS overviewAll 13F holders of CRVSFull Q2 2026 holdings
- Shares (Q2 2026)
- 70,000
- Value
- $1.05M
- % of portfolio
- 0.7%
- Quarters held
- 13
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 70,000 | $1.05M | 0.7% | 00.0% | Unchanged | Holders |
| Q1 2026 | 70,000 | $1.02M | 0.7% | −70,000−50.0% | Reduced | Holders |
| Q4 2025 | 140,000 | $1.08M | 0.8% | −30,000−17.6% | Reduced | Holders |
| Q3 2025 | 170,000 | $1.25M | 0.9% | 00.0% | Unchanged | Holders |
| Q2 2025 | 170,000 | $680.0K | 0.5% | +42,500+33.3% | Added | Holders |
| Q1 2025 | 127,500 | $405.4K | 0.3% | +50,000+64.5% | Added | Holders |
| Q4 2024 | 77,500 | $414.6K | 0.3% | −40,000−34.0% | Reduced | Holders |
| Q3 2024 | 117,500 | $620.4K | 0.4% | −282,500−70.6% | Reduced | Holders |
| Q2 2024 | 400,000 | $728.0K | 0.5% | +17,500+4.6% | Added | Holders |
| Q1 2024 | 382,500 | $680.9K | 0.5% | −54,373−12.4% | Reduced | Holders |
| Q4 2023 | 436,873 | $768.9K | 0.5% | +94,395+27.6% | Added | Holders |
| Q3 2023 | 342,478 | $500.0K | 0.3% | +137,478+67.1% | Added | Holders |
| Q2 2023 | 205,000 | $469.4K | 0.3% | +205,000 | New | Holders |